Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Rami Manochakian, MD"'
Autor:
Umair Majeed, MD, Shenduo Li, MD, PhD, Karan Seegobin, MBBS, Aziza Nassar, MD, Rami Manochakian, MD, Yujie Zhao, MD, PhD, Yanyan Lou, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 7, Pp 100536- (2023)
ALK-EML4 fusion-positive lung adenocarcinomas (LUADs) are effectively treated with ALK tyrosine kinase inhibitors, but most patients eventually develop resistance to these drugs owing to ALK-dependent or independent mechanisms. Endothelial to mesench
Externí odkaz:
https://doaj.org/article/3c73aa028f9b41f9bb76d26b039694fb
